Please use this identifier to cite or link to this item:
Title: Formoterol and cancer wasting in rats: effects on muscle force and total physical activity
Author: Toledo Soler, Míriam
Busquets Rius, Sílvia
Sirisi Dolcet, Sònia
Orpí, Marcel
Serpe, Roberto
Coutinho, Joana
Martínez, Raquel
Argilés Huguet, Josep Ma.
López-Soriano, Francisco J.
Keywords: Càncer
Atròfia muscular
Aparell locomotor
Teràpia genètica
Muscular atrophy
Musculoskeletal system
Gene therapy
Issue Date: Jun-2011
Publisher: Spandidos Publications
Abstract: Cancer cachexia occurs in the majority of cancer patients before death, and it is responsible for the death of 22% of cancer patients. One of the most relevant characteristics of cachexia is that of asthenia, which reflects significant muscle wasting noted in cachectic cancer patients The aim of the present study was to assess whether the ?2-adrenergic agonist formoterol is associated with an improvement in physiological parameters such as grip force and total physical activity in cachetic rats. Administration of the ?2-agonist formoterol (0.3 mg/kg for 7 days) in rats bearing Yoshida AH-130 ascites hepatoma tumors, a model which induces a strong loss of both body and muscle weight, resulted in a significant reversal of the muscle wasting process, as reflected by individual muscle weights. The anti-wasting effects of the drug were also observed in terms of total physical activity and grip force, thus resulting in an improvement in physical performance in cachectic tumor-bearing rats.
Note: Reproducció del document publicat a:
It is part of: Experimental and Therapeutic Medicine, 2011, vol. 2, num. 4, p. 731-735
Related resource:
ISSN: 1792-0981
Appears in Collections:Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Files in This Item:
File Description SizeFormat 
601182.pdf512.5 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.